Bright Minds Biosciences ... (DRUG)
NASDAQ: DRUG
· Real-Time Price · USD
43.95
0.68 (1.57%)
At close: Sep 04, 2025, 3:59 PM
43.00
-2.16%
Pre-market: Sep 05, 2025, 09:11 AM EDT
1.57% (1D)
| Bid | 35.88 |
| Market Cap | 311.37M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.89M |
| EPS (ttm) | -1 |
| PE Ratio (ttm) | -43.95 |
| Forward PE | -8.04 |
| Analyst | Buy |
| Ask | 45.91 |
| Volume | 461,029 |
| Avg. Volume (20D) | 47,946 |
| Open | 44.65 |
| Previous Close | 43.27 |
| Day's Range | 41.57 - 46.44 |
| 52-Week Range | 0.94 - 79.02 |
| Beta | -0.14 |
About DRUG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DRUG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DRUG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+3.36%
Shares of psychedelic companies are trading higher...
Unlock content with
Pro Subscription
9 months ago
-1.24%
Bright Minds Biosciences shares are trading higher after Baird initiated coverage on the stock with an Outperform rating and announced a price target of $75.
